Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Balu

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Biopharmaceutics & Drug Disposition|July 16, 2016
Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A miceKrithika A Shetty, Matthew P Kosloski, Donald E Mager, et al.
Cellular Immunology|December 31, 2022
Phosphatidylserine-mediated oral toleranceNhan H Nguyen, Vincent Chak, Katherine Keller, et al.
The AAPS Journal|December 17, 2011
PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A miceAaron Peng, Matthew P Kosloski, Genki Nakamura, et al.
Journal of Pharmaceutical Sciences|April 27, 2013
Allometry of factor VIII and informed scaling of next-generation therapeutic proteinsMatthew P Kosloski, Dipak S Pisal, Donald E Mager, et al.
Biopharmaceutics & Drug Disposition|November 8, 2014
Effects of hypertonic buffer composition on lymph node uptake and bioavailability of rituximab, after subcutaneous administrationAnas M Fathallah, Michael R Turner, Donald E Mager, et al.
Journal of Pharmaceutical Sciences|April 5, 2014
Soy phosphatidylinositol containing nanoparticle prolongs hemostatic activity of B-domain deleted factor VIII in hemophilia A miceKrithika A Shetty, Matthew P Kosloski, Donald E Mager, et al.
Biopharmaceutics & Drug Disposition|November 22, 2013
Nonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A miceMatthew P Kosloski, Dipak S Pisal, Donald E Mager, et al.
Nanomaterials (Basel, Switzerland)|April 13, 2026
Intestinal Microfold Cells Play a Critical Role in the Uptake and Oral Tolerance Mediated by Lysophosphatidylserine-Containing Lipidic NanoparticlesVincent Chak, Sujay Harne, Jason G Kay, et al.
Chest|May 1, 1982
Mitral regurgitation in coronary artery diseaseV Balu, S Hershowitz, A R Zaki Masud, et al.
Journal of Pharmaceutical Sciences|May 15, 2012
Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinibBrian J Trummer, Vandana Iyer, Sathy V Balu-Iyer, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Biopharmaceutics & Drug Disposition|July 16, 2016
Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A miceKrithika A Shetty, Matthew P Kosloski, Donald E Mager, et al.
Cellular Immunology|December 31, 2022
Phosphatidylserine-mediated oral toleranceNhan H Nguyen, Vincent Chak, Katherine Keller, et al.
The AAPS Journal|December 17, 2011
PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A miceAaron Peng, Matthew P Kosloski, Genki Nakamura, et al.
Journal of Pharmaceutical Sciences|April 27, 2013
Allometry of factor VIII and informed scaling of next-generation therapeutic proteinsMatthew P Kosloski, Dipak S Pisal, Donald E Mager, et al.
Biopharmaceutics & Drug Disposition|November 8, 2014
Effects of hypertonic buffer composition on lymph node uptake and bioavailability of rituximab, after subcutaneous administrationAnas M Fathallah, Michael R Turner, Donald E Mager, et al.
Journal of Pharmaceutical Sciences|April 5, 2014
Soy phosphatidylinositol containing nanoparticle prolongs hemostatic activity of B-domain deleted factor VIII in hemophilia A miceKrithika A Shetty, Matthew P Kosloski, Donald E Mager, et al.
Biopharmaceutics & Drug Disposition|November 22, 2013
Nonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A miceMatthew P Kosloski, Dipak S Pisal, Donald E Mager, et al.
Nanomaterials (Basel, Switzerland)|April 13, 2026
Intestinal Microfold Cells Play a Critical Role in the Uptake and Oral Tolerance Mediated by Lysophosphatidylserine-Containing Lipidic NanoparticlesVincent Chak, Sujay Harne, Jason G Kay, et al.
Chest|May 1, 1982
Mitral regurgitation in coronary artery diseaseV Balu, S Hershowitz, A R Zaki Masud, et al.
Journal of Pharmaceutical Sciences|May 15, 2012
Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinibBrian J Trummer, Vandana Iyer, Sathy V Balu-Iyer, et al.
Pageof 8